351![Microsoft PowerPoint - full.ppt Microsoft PowerPoint - full.ppt](https://www.pdfsearch.io/img/334c08b3e546bdcca1bbcbe3303c618d.jpg) | Add to Reading ListSource URL: www.accp1.orgLanguage: English - Date: 2011-03-25 17:31:30
|
---|
352![XXXXXXX EMEND® (aprepitant) CAPSULES DESCRIPTION XXXXXXX EMEND® (aprepitant) CAPSULES DESCRIPTION](https://www.pdfsearch.io/img/87dcc2da67c80ae76f0b6bc240927070.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:51:10
|
---|
353![sPeCiAl ArTiCle Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn’s disease Daniel C Sadowski MD1, Charles N Bernstein MD2, Alai sPeCiAl ArTiCle Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn’s disease Daniel C Sadowski MD1, Charles N Bernstein MD2, Alai](https://www.pdfsearch.io/img/547b1b49c3b64bfb2ebe09881daad023.jpg) | Add to Reading ListSource URL: www.cag-acg.orgLanguage: English - Date: 2011-05-26 17:34:53
|
---|
354![Microsoft Word - Kansas Hypertension Outcomes.doc Microsoft Word - Kansas Hypertension Outcomes.doc](https://www.pdfsearch.io/img/25b5f5c8ff2779850997faa44354a894.jpg) | Add to Reading ListSource URL: www.kdheks.govLanguage: English - Date: 2012-02-06 11:16:09
|
---|
355![Kappa Opioid Receptor Agonists and Antagonist Summary: The present invention is an entirely new chemotype of KOR weak partial agonists. Contact Information: Matt Koenig, J.D. KU Innovation & Collaboration[removed]m Kappa Opioid Receptor Agonists and Antagonist Summary: The present invention is an entirely new chemotype of KOR weak partial agonists. Contact Information: Matt Koenig, J.D. KU Innovation & Collaboration[removed]m](https://www.pdfsearch.io/img/8f80cae36e864da8e84d4645cbab9b5e.jpg) | Add to Reading ListSource URL: kuic.ku.eduLanguage: English - Date: 2014-01-30 10:26:50
|
---|
356![Novel Methods for Antagonizing Kappa Opioid Receptors Summary: The invention is a method for antagonizing kappa opioid receptors (KOR) present in tissue in vitro or in vivo. Contact Information: Aswini K. Betha, Ph.D. KU Novel Methods for Antagonizing Kappa Opioid Receptors Summary: The invention is a method for antagonizing kappa opioid receptors (KOR) present in tissue in vitro or in vivo. Contact Information: Aswini K. Betha, Ph.D. KU](https://www.pdfsearch.io/img/900c1c9ff4f3e1d2beaad1664e43f504.jpg) | Add to Reading ListSource URL: kuic.ku.eduLanguage: English - Date: 2014-01-30 10:23:55
|
---|
357![Design of an Agonist-Antagonist Active Knee Prosthesis Design of an Agonist-Antagonist Active Knee Prosthesis](https://www.pdfsearch.io/img/505db697bd51a97403110829496a353b.jpg) | Add to Reading ListSource URL: biomech.media.mit.eduLanguage: English - Date: 2013-06-20 17:54:31
|
---|
358![TAKE HOME NALOXONE: KEY POINTS FOR MEDICAL, ETHICAL AND LEGAL CONCERNS Naloxone is a medication that saves lives by reversing the effects of an overdose from opioids (e.g. heroin, methadone, morphine). BC’s Take Home N TAKE HOME NALOXONE: KEY POINTS FOR MEDICAL, ETHICAL AND LEGAL CONCERNS Naloxone is a medication that saves lives by reversing the effects of an overdose from opioids (e.g. heroin, methadone, morphine). BC’s Take Home N](https://www.pdfsearch.io/img/de495e37c0f76a1b4f977e63f7dc2924.jpg) | Add to Reading ListSource URL: towardtheheart.comLanguage: English - Date: 2014-11-21 20:00:26
|
---|
359![Workloop Energetics of Antagonist Muscles Workloop Energetics of Antagonist Muscles](https://www.pdfsearch.io/img/64e231695c2400c0fbe2ce7b15de8ca4.jpg) | Add to Reading ListSource URL: biomech.media.mit.eduLanguage: English - Date: 2013-07-10 18:28:47
|
---|
360![Microsoft Word - KS Diabetes Outcomes.doc Microsoft Word - KS Diabetes Outcomes.doc](https://www.pdfsearch.io/img/a8f970fef67d7d92b1a7c3c6d12dcd9e.jpg) | Add to Reading ListSource URL: www.kdheks.govLanguage: English - Date: 2012-02-06 11:16:00
|
---|